Clinical Trial Update: Vasoconstriction Trial With LEO 90100 Aerosol Foam [Phase 1]

View source ↗

Summary

The document reports the completion of a Phase 1 trial evaluating LEO 90100 aerosol foam for psoriasis vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• LEO 90100 Aerosol Foam

Snippet

Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 1 | Status: COMPLETED